PROTEZ PHARMACEUTICALS INC has a total of 20 patent applications. Its first patent ever was published in 2004. It filed its patents most often in Taiwan, WIPO (World Intellectual Property Organization) and Argentina. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are AMEDIS PHARM LTD, PHENOMIX CORP and NEWGEN THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Argentina | 2 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Tunisia | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Burns Christopher J | 17 |
#2 | Jackson Randy W | 17 |
#3 | Goswami Rajesh | 9 |
#4 | Xu Hongyu | 8 |
#5 | Rajesh Goswami | 1 |
#6 | Klyachko Ekaterina A | 1 |
#7 | Johnson Michael E | 1 |
#8 | Pevear Daniel | 1 |
#9 | Tirunahari Pavan Kumar | 1 |
#10 | Xu Hong-Yu | 1 |
Publication | Filing date | Title |
---|---|---|
EP2220096A1 | Beta-lactamase inhibitors |